Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial DNA and intracellular proteins represent a composite target for broad-spectrum antimicrobial agents, primarily antiseptics and heavy metals. This target includes the bacterial chromosome, which is essential for genetic inheritance and protein synthesis, and the cytoplasmic proteome, which encompasses all enzymes and structural proteins required for metabolism (PubMed: 16702442). Unlike targeted antibiotics that inhibit specific pathways, agents acting on these components often cause widespread damage by denaturing proteins and disrupting the integrity of nucleic acids (PubMed: 12673917). For instance, silver ions are known to bind to DNA bases and functional groups in proteins, leading to the cessation of cellular respiration and division (PubMed: 21034431). While highly effective at killing a wide range of pathogens, the lack of specificity often limits these agents to topical applications to avoid damage to human cells (PubMed: 15907336). This multi-target approach is particularly valuable in preventing the development of bacterial resistance, as simultaneous mutations in multiple essential components are highly unlikely.
Antimicrobial agents targeting these components typically act via non-specific mechanisms: silver ions bind to bacterial DNA, preventing replication, and interact with thiol groups on proteins, causing denaturation (PubMed: 21034431). Oxidizing agents like povidone-iodine oxidize essential cellular components, including proteins and nucleic acids, leading to rapid cell death (PubMed: 15907336).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial DNA and intracellular proteins.